Companies: 10,795·Total market cap: $144.5T
Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTKNASDAQHealthcare● Active
$67.90
$-3.58(-5.01%)
Market Cap$8.4B
P/E Ratio
52W High$80.2
52W Low$31.99
Overview

Cytokinetics, Incorporated(CYTK)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CYTK · 截至 2026-06-10

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($784.96M)($589.53M)($526.24M)($388.95M)($215.31M)
Depreciation & Amort.$10.13M$9.53M$11.89M$5.81M$2.28M
Stock-Based Comp.$0.00M$97.84M$72.06M$47.85M$26.83M
Change in Working Capital($35.63M)$35.66M$3.09M($24.70M)$8.46M
Net Cash from Operations($510.01M)($395.89M)($414.33M)($299.52M)($142.52M)
Investing Activities
Capital Expenditure($24.81M)($3.91M)($1.42M)($11.34M)($48.87M)
Purchases of Investments($1063.17M)($1293.42M)($635.21M)($855.39M)($525.04M)
Sales of Investments$1109.65M$744.23M$875.88M$604.59M$426.14M
Net Cash from Investing$16.67M($553.10M)$239.25M($262.13M)($147.78M)
Financing Activities
Common Stock Repurchased$0.00M$0.00M$0.00M$0.00M$0.00M
Dividends Paid$0.00M$0.00M$0.00M$0.00M$0.00M
Debt Issued / Repaid$490.95M($9.62M)($0.86M)$334.66M$0.00M
Net Cash from Financing$524.46M$930.61M$221.32M$516.17M$319.98M
Free Cash Flow
Free Cash Flow($534.82M)($399.80M)($415.75M)($310.85M)($191.39M)
FCF Margin %(computed)-607.48%-328.64%-271.76%

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Cytokinetics, Incorporated

关于Cytokinetics, Incorporated(CYTK)现金流量表

Cytokinetics, Incorporated 2025财年经营活动现金流($0.51B),自由现金流($0.53B)(FCF利润率-607.48%),资本支出($0.02B)。

常见问题

CYTK · 4 问

Cytokinetics, Incorporated 2025财年自由现金流($0.53B),同比down33.8%。

CYTK free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10